FRUQUINTINIB
Clinical trials for FRUQUINTINIB explained in plain language.
Never miss a new study
Get alerted when new FRUQUINTINIB trials appear
Sign up with your email to follow new studies for FRUQUINTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo targets 'Hidden' colon cancer after chemo
Disease control Recruiting nowThis study is testing whether a combination of two drugs, fruquintinib and tislelizumab, can help control colorectal cancer in patients who have finished their initial chemotherapy but still have tiny amounts of cancer left in their body, detected by a special blood test. The goa…
Matched conditions: FRUQUINTINIB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 03:05 UTC
-
New hope for advanced colon cancer: skipping chemo?
Disease control Recruiting nowThis study is testing a new first-line treatment for advanced colorectal cancer that aims to avoid chemotherapy. It combines targeted drugs that block cancer growth signals with or without immunotherapy drugs that help the immune system fight cancer. The goal is to see if this ch…
Matched conditions: FRUQUINTINIB
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for tough stomach cancers: testing a Triple-Threat treatment
Disease control Recruiting nowThis study is testing a new three-drug combination for people with advanced stomach or gastroesophageal cancer that has a specific marker called HER2-positive. The main goals are to find the safest and most effective dose of the new drug fruquintinib when added to two standard ca…
Matched conditions: FRUQUINTINIB
Phase: PHASE1, PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC